In a study using immunocompetent C57BL/6 mice with B10-F10 melanoma tumors as a model for melanoma resistance to immunotherapies, FTO knockdown restored the efficacy of anti-PD-1 blockade and significantly inhibited tumor growth (85). The gene discussed is PDCD1; the disease is melanoma.